{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:40:34Z","timestamp":1790073634849,"version":"4.0.1"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ejim.2021.08.010","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T07:49:56Z","timestamp":1630482596000},"page":"35-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Surveillance and management of colorectal dysplasia and cancer in inflammatory bowel disease: Current practice and future perspectives"],"prefix":"10.1016","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1277-1796","authenticated-orcid":false,"given":"Anouk M.","family":"Wijnands","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4138-3058","authenticated-orcid":false,"given":"Remi","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice W.M.D.","family":"Lutgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas","family":"Oldenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2021.08.010_bib0001","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00000441-192508010-00006","article-title":"The sigmoidoscopic picture of chronic ulcerative colitis (non- specific)","volume":"170","author":"Crohn","year":"1925","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ejim.2021.08.010_bib0002","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1053\/j.gastro.2012.04.016","article-title":"Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years","volume":"143","author":"Jess","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2021.08.010_bib0003","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/MIB.0b013e31828029c0","article-title":"Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies","volume":"19","author":"Lutgens","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ejim.2021.08.010_bib0004","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","article-title":"ECCO-ESGAR guideline for diagnostic assessment in IBD Part 1: initial diagnosis, monitoring of known IBD, detection of complications","volume":"13","author":"Maaser","year":"2019","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.ejim.2021.08.010_bib0005","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2021.08.010_bib0006","doi-asserted-by":"crossref","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","article-title":"ACG clinical guideline: ulcerative colitis in adults","volume":"114","author":"Rubin","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2021.08.010_bib0007","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ajg.2018.27","article-title":"ACG clinical guideline: management of Crohn's disease in adults","volume":"113","author":"Lichtenstein","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2021.08.010_bib0008","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1053\/j.gastro.2009.12.037","article-title":"AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease","volume":"138","author":"Farraye","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2021.08.010_bib0009","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1038\/s41395-018-0354-7","article-title":"Strategies for detecting colorectal cancer in patients with inflammatory bowel disease: a cochrane systematic review and meta-analysis","volume":"113","author":"Bye","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2021.08.010_bib0010","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/ecco-jcc\/jjaa158","article-title":"Endoscopic submucosal dissection for visible dysplasia treatment in ulcerative colitis patients: cases series and systematic review of literature","volume":"15","author":"Manta","year":"2021","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.ejim.2021.08.010_bib0011","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clim.2018.03.004","article-title":"Biological therapies in inflammatory bowel disease: beyond anti-TNF therapies","volume":"206","author":"Katsanos","year":"2019","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ejim.2021.08.010_bib0012","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/gutjnl-2016-312912","article-title":"Next generation of small molecules in inflammatory bowel disease","volume":"66","author":"Olivera","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2021.08.010_bib0013","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","article-title":"A genetic model for colorectal tumorigenesis","volume":"61","author":"Fearon","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.ejim.2021.08.010_bib0014","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.gtc.2006.07.002","article-title":"Molecular biology of dysplasia and cancer in inflammatory bowel disease","volume":"35","author":"Itzkowitz","year":"2006","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.ejim.2021.08.010_bib0015","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0046-8177(83)80175-0","article-title":"Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications","volume":"14","author":"Riddell","year":"1983","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejim.2021.08.010_bib0016","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/gutjnl-2017-314190","article-title":"Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: a large single-centre study","volume":"68","author":"Choi","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2021.08.010_bib0017","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1053\/j.gastro.2020.12.036","article-title":"Prognostic Factors for Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: Systematic Review and Meta-analysis","volume":"160","author":"Wijnands","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2021.08.010_bib0018","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.canlet.2012.02.031","article-title":"Pan-colonic field defects are detected by CGH in the colons of UC patients with dysplasia\/cancer","volume":"320","author":"Lai","year":"2012","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ejim.2021.08.010_bib0019","first-page":"161","article-title":"Clinical implications of low grade dysplasia found during inflammatory bowel disease surveillance: a retrospective study comparing chromoendoscopy and white-light endoscopy","volume":"49","author":"Ten Hove","year":"2017","journal-title":"Endoscopy"},{"key":"10.1016\/j.ejim.2021.08.010_bib0020","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.cgh.2019.08.032","article-title":"Association between indefinite dysplasia and advanced neoplasia in patients with inflammatory bowel diseases undergoing surveillance","volume":"18","author":"Mahmoud","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2021.08.010_bib0021","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ajg.2015.248","article-title":"Low-grade dysplasia in ulcerative colitis: risk factors for developing high-grade dysplasia or colorectal cancer","volume":"110","author":"Choi","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2021.08.010_bib0022","article-title":"Molecular characterization of ulcerative colitis-associated colorectal carcinomas","author":"Hirsch","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejim.2021.08.010_bib0023","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/ibd\/izz171","article-title":"IBD-Associated Dysplastic Lesions Show More Chromosomal Instability Than Sporadic Adenomas","volume":"26","author":"Wanders","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ejim.2021.08.010_bib0024","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/modpathol.2013.133","article-title":"Diagnostic utility of TP53 and cytokeratin 7 immunohistochemistry in idiopathic inflammatory bowel disease-associated neoplasia","volume":"27","author":"Xie","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejim.2021.08.010_bib0025","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/gastro\/gov022","article-title":"Overexpression of p53 predicts colorectal neoplasia risk in patients with inflammatory bowel disease and mucosa changes indefinite for dysplasia","volume":"3","author":"Horvath","year":"2015","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"10.1016\/j.ejim.2021.08.010_bib0026","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1053\/j.gastro.2019.11.294","article-title":"Differences in gut microbiota in patients with vs without inflammatory bowel diseases: a systematic review","volume":"158","author":"Pittayanon","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2021.08.010_bib0027","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1126\/science.1224820","article-title":"Intestinal inflammation targets cancer-inducing activity of the microbiota","volume":"338","author":"Arthur","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.ejim.2021.08.010_bib0028","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41586-020-2080-8","article-title":"Mutational signature in colorectal cancer caused by genotoxic pks(+) E. coli","volume":"580","author":"Pleguezuelos-Manzano","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejim.2021.08.010_bib0029","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/s41467-021-21162-y","article-title":"Genomic aberrations after short-term exposure to colibactin-producing E. coli transform primary colon epithelial cells","volume":"12","author":"Iftekhar","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejim.2021.08.010_bib0030","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ajg.2015.65","article-title":"Forty-year analysis of colonoscopic surveillance program for neoplasia in ulcerative colitis: an updated overview","volume":"110","author":"Choi","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2021.08.010_bib0031","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1053\/j.gastro.2013.03.044","article-title":"Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease","volume":"145","author":"Beaugerie","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2021.08.010_bib0032","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(19)32545-0","article-title":"Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study","volume":"395","author":"Olen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2021.08.010_bib0033","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2468-1253(20)30005-4","article-title":"Colorectal cancer in Crohn's disease: a Scandinavian population-based cohort study","volume":"5","author":"Olen","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2021.08.010_bib0034","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s10620-015-3940-1","article-title":"Survival of colorectal cancer in patients with or without inflammatory bowel disease: a meta-analysis","volume":"61","author":"Ou","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ejim.2021.08.010_bib0035","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/apt.16155","article-title":"Root-cause analyses of missed opportunities for the diagnosis of colorectal cancer in patients with inflammatory bowel disease","volume":"53","author":"Gordon","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2021.08.010_bib0036","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.cgh.2013.05.017","article-title":"Long-term follow-up reveals low incidence of colorectal cancer, but frequent need for resection, among Australian patients with inflammatory bowel disease","volume":"12","author":"Selinger","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2021.08.010_bib0037","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/ecco-jcc\/jjy044","article-title":"Incidence and classification of postcolonoscopy colorectal cancers in inflammatory bowel disease: a dutch population-based cohort study","volume":"12","author":"Wintjens","year":"2018","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.ejim.2021.08.010_bib0038","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.cgh.2018.01.023","article-title":"High risk of advanced colorectal neoplasia in patients with primary sclerosing cholangitis associated with inflammatory bowel disease","volume":"16","author":"Shah","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2021.08.010_bib0039","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJMra1506330","article-title":"Primary sclerosing cholangitis","volume":"375","author":"Lazaridis","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2021.08.010_bib0040","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0016-5085(91)70019-T","article-title":"Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis","volume":"100","author":"Olsson","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2021.08.010_bib0041","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.gie.2014.02.1031","article-title":"A risk-profiling approach for surveillance of inflammatory bowel disease-colorectal carcinoma is more cost-effective: a comparative cost-effectiveness analysis between international guidelines","volume":"80","author":"Lutgens","year":"2014","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.ejim.2021.08.010_bib0042","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.cgh.2015.04.183","article-title":"Incidence of interval colorectal cancer among inflammatory bowel disease patients undergoing regular colonoscopic surveillance","volume":"13","author":"Mooiweer","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2021.08.010_bib0043","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/apt.16284","article-title":"Letter: colorectal cancer surveillance in inflammatory bowel disease-a call for systematic reform","volume":"53","author":"Prentice","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2021.08.010_bib0044","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/apt.16175","article-title":"Editorial: missed opportunities to detect colorectal cancer in inflammatory bowel disease-getting to the root","volume":"53","author":"Mahmoud","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2021.08.010_bib0045","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1053\/j.gastro.2015.09.041","article-title":"Quantification of adequate bowel preparation for screening or surveillance colonoscopy in men","volume":"150","author":"Clark","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2021.08.010_bib0046","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1053\/j.gastro.2015.01.031","article-title":"SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease","volume":"148","author":"Laine","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2021.08.010_bib0047","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.vgie.2017.11.004","article-title":"The use of chromoendoscopy for surveillance of inflammatory bowel disease","volume":"3","author":"Lichtenstein","year":"2018","journal-title":"VideoGIE"},{"key":"10.1016\/j.ejim.2021.08.010_bib0048","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.cgh.2016.11.021","article-title":"Chromoendoscopy for surveillance in ulcerative colitis and crohn's disease: a systematic review of randomized trials","volume":"15","author":"Iannone","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2021.08.010_bib0049","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.gie.2019.04.219","article-title":"Meta-analysis of dye-based chromoendoscopy compared with standard- and high-definition white-light endoscopy in patients with inflammatory bowel disease at increased risk of colon cancer","volume":"90","author":"Feuerstein","year":"2019","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.ejim.2021.08.010_bib0050","doi-asserted-by":"crossref","first-page":"E578","DOI":"10.1055\/a-1120-8376","article-title":"Surveillance in inflammatory bowel disease: is chromoendoscopy the only way to go? A systematic review and meta-analysis of randomized clinical trials","volume":"8","author":"Resende","year":"2020","journal-title":"Endosc Int Open"},{"key":"10.1016\/j.ejim.2021.08.010_bib0051","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.cgh.2020.04.049","article-title":"High-definition chromoendoscopy superior to high-definition white-light endoscopy in surveillance of inflammatory bowel diseases in a randomized trial","volume":"18","author":"Alexandersson","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2021.08.010_bib0052","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/gutjnl-2016-311892","article-title":"Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?","volume":"67","author":"Moussata","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2021.08.010_bib0053","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1053\/j.gastro.2016.08.002","article-title":"Comparison of targeted vs random biopsies for surveillance of ulcerative colitis-associated colorectal cancer","volume":"151","author":"Watanabe","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2021.08.010_bib0054","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/ibd\/izaa146","article-title":"A 1-year cross-sectional inflammatory bowel disease surveillance colonoscopy cohort comparing high-definition white light endoscopy and chromoendoscopy","volume":"27","author":"Coelho-Prabhu","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ejim.2021.08.010_bib0055","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.crohns.2013.02.009","article-title":"Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis","volume":"7","author":"Navaneethan","year":"2013","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.ejim.2021.08.010_bib0056","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/gutjnl-2017-315440","article-title":"Consecutive negative findings on colonoscopy during surveillance predict a low risk of advanced neoplasia in patients with inflammatory bowel disease with long-standing colitis: results of a 15-year multicentre, multinational cohort study","volume":"68","author":"Ten Hove","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2021.08.010_bib0057","unstructured":"Nederlandse Vereniging van Maag-, Darm- en Leverartsen, Handleiding behandeling IBD - 2014-2015. (Accessed April 8, 2021, at https:\/\/www.mdl.nl\/sites\/www.mdl.nl\/files\/richlijnen\/Document_volledig_Handleiding_met_literatuur_def.pdf)."},{"key":"10.1016\/j.ejim.2021.08.010_bib0058","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/01.MIB.0000438428.30800.a6","article-title":"Fecal hemoglobin and calprotectin are equally effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation","volume":"20","author":"Mooiweer","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ejim.2021.08.010_bib0059","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.crohns.2013.06.001","article-title":"European consensus on the histopathology of inflammatory bowel disease","volume":"7","author":"Magro","year":"2013","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.ejim.2021.08.010_bib0060","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/modpathol.3880534","article-title":"Interobserver variability in the diagnosis of ulcerative colitis-associated dysplasia by telepathology","volume":"15","author":"Odze","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejim.2021.08.010_bib0061","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/ibd.21467","article-title":"Misclassification of dysplasia in patients with inflammatory bowel disease: consequences for progression rates to advanced neoplasia","volume":"17","author":"van Schaik","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ejim.2021.08.010_bib0062","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/gastro\/gou031","article-title":"Histological evaluation in ulcerative colitis","volume":"2","author":"DeRoche","year":"2014","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"10.1016\/j.ejim.2021.08.010_bib0063","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjab011","article-title":"ECCO topical review optimising reporting in surgery, endoscopy, and histopathology","author":"Adamina","year":"2021","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.ejim.2021.08.010_bib0064","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.gie.2015.02.052","article-title":"Curative endoscopic submucosal dissection of large nonpolypoid superficial neoplasms in ulcerative colitis (with videos)","volume":"82","author":"Iacopini","year":"2015","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.ejim.2021.08.010_bib0065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cgh.2018.07.041","article-title":"AGA institute clinical practice update: endoscopic submucosal dissection in the United States","volume":"17","author":"Draganov","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2021.08.010_bib0066","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.crohns.2014.08.012","article-title":"European evidence based consensus on surgery for ulcerative colitis","volume":"9","author":"Oresland","year":"2015","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.ejim.2021.08.010_bib0067","first-page":"1","article-title":"ECCO-ESCP consensus on surgery for Crohn's disease","volume":"12","author":"Bemelman","year":"2018","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.ejim.2021.08.010_bib0068","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/ibd\/izy253","article-title":"Malignant and nonmalignant complications of the rectal stump in patients with inflammatory bowel disease","volume":"25","author":"Ten Hove","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ejim.2021.08.010_bib0069","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/apt.13763","article-title":"Systematic review: outcomes and post-operative complications following colectomy for ulcerative colitis","volume":"44","author":"Peyrin-Biroulet","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2021.08.010_bib0070","article-title":"The relation between disease activity, quality of life and health utility in patients with ulcerative colitis","author":"Woehl","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2021.08.010_bib0071","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/apt.14023","article-title":"Systematic review with meta-analysis: use of 5-aminosalicylates and risk of colorectal neoplasia in patients with inflammatory bowel disease","volume":"45","author":"Bonovas","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2021.08.010_bib0072","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.18632\/oncotarget.13715","article-title":"Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis","volume":"8","author":"Qiu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejim.2021.08.010_bib0073","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000353806","article-title":"Peyrin-Biroulet L. 5-Aminosalicylic acid and chemoprevention: does it work?","volume":"31","author":"Lopez","year":"2013","journal-title":"Dig Dis"},{"key":"10.1016\/j.ejim.2021.08.010_bib0074","article-title":"Prognostic factors for advanced colorectal neoplasia in inflammatory bowel disease: systematic review and meta-analysis","author":"Wijnands","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2021.08.010_bib0075","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/ecco-jcc\/jjy006","article-title":"Reduced risk of inflammatory bowel disease-associated colorectal neoplasia with use of thiopurines: a systematic review and meta-analysis","volume":"12","author":"Zhu","year":"2018","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.ejim.2021.08.010_bib0076","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/apt.14436","article-title":"Systematic review with meta-analysis: thiopurines decrease the risk of colorectal neoplasia in patients with inflammatory bowel disease","volume":"47","author":"Lu","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2021.08.010_bib0077","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/MIB.0b013e318286fa61","article-title":"Effect of ursodeoxycholic acid use on the risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis","volume":"19","author":"Singh","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ejim.2021.08.010_bib0078","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2021.08.010_bib0079","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/ajg.2011.156","article-title":"High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"106","author":"Eaton","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2021.08.010_bib0080","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1136\/gutjnl-2018-317993","article-title":"British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis","volume":"68","author":"Chapman","year":"2019","journal-title":"Gut"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620521002764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620521002764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:34:28Z","timestamp":1760607268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620521002764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":80,"alternative-id":["S0953620521002764"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2021.08.010","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surveillance and management of colorectal dysplasia and cancer in inflammatory bowel disease: Current practice and future perspectives","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2021.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}]}}